Mark W. Begor - 23 Oct 2026 Form 4 Insider Report for EQUIFAX INC (EFX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Oct 2026, 16:16:57 UTC
Prior SEC filing
28 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Lisa Stockard as Attorney-in-Fact
Filing notes and source

Key filing fact

Mark W. Begor filed Form 4 for EQUIFAX INC (EFX) on 27 Oct 2026.

Key facts

  • This page summarizes Mark W. Begor's Form 4 filing for EQUIFAX INC (EFX).
  • 6 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Oct 2026, 16:16.

Change

  • Previous filing in this sequence was filed on 28 Jul 2026.
  • Current net transaction value: -$6,908,340.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001335111 Primary reporting owner

Begor Mark W

Relationship
CEO, Director
Address
1550 PEACHTREE STREET, N.W., ATLANTA
Signature
/s/Lisa Stockard as Attorney-in-Fact
Signature date
27 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EFX transaction

Common Stock

Options Exercise

Transaction value
Shares
+37,792
Change %
+13%
Price
$112.46*
Shares after
327,714
Date
23 Oct 2026
Ownership
Direct
Footnotes
F1, F2
EFX transaction

Common Stock

Sale

Transaction value
-$222,960
Shares
-1,194
Change %
-0.36%
Price
$186.73
Shares after
326,520
Date
23 Oct 2026
Ownership
Direct
Footnotes
F1, F2, F3
EFX transaction

Common Stock

Sale

Transaction value
-$229,254
Shares
-1,250
Change %
-0.38%
Price
$183.40
Shares after
325,270
Date
23 Oct 2026
Ownership
Direct
Footnotes
F1, F2
EFX transaction

Common Stock

Sale

Transaction value
-$311,327
Shares
-1,681
Change %
-0.52%
Price
$185.20
Shares after
323,589
Date
23 Oct 2026
Ownership
Direct
Footnotes
F1, F2, F4
EFX transaction

Common Stock

Sale

Transaction value
-$6,144,800
Shares
-33,667
Change %
-10%
Price
$182.52
Shares after
289,922
Date
23 Oct 2026
Ownership
Direct
Footnotes
F1, F2, F5
EFX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,350
Date
23 Oct 2026
Ownership
2-yr Apr 2025 GRAT
EFX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
21,284
Date
23 Oct 2026
Ownership
2-yr Dec 2025 GRAT
EFX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
20,512
Date
23 Oct 2026
Ownership
2-yr Jun 2025 GRAT
EFX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,018
Date
23 Oct 2026
Ownership
2-yr May 2025 GRAT
EFX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
18,562
Date
23 Oct 2026
Ownership
2-yr May 2026 GRAT

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EFX transaction Derivative

Stock Option/Right to Buy

Options Exercise

Transaction value
Shares
-37,792
Change %
-100%
Price
$0.000000*
Shares after
0
Date
23 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
37,792
Exercise price
$112.46
Footnotes
F1, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025.

Footnote F2

Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

Footnote F3

The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $186.6698 to $187.43, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Footnote F4

The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $184.9466 to $185.5977, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Footnote F5

The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $181.7387 to $182.6225, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Footnote F6

The option vested in three equal annual increments beginning 5/4/2019.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .